Showing results (1731-1740 of 4,265) with videos related to
Sort By:
Pageof 427
Cancer Discovery|December 6, 2018
Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic LeukemiaPiers Blombery, Mary Ann Anderson, Jia-Nan Gong, et al.Cancer Discovery|December 7, 2018
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast CancerSheau W Lok, James R Whittle, François Vaillant, et al.Cancer Discovery|December 12, 2018
First-Line Ibrutinib Confirmed for CLLCancer Discovery|March 23, 2018
Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Nonhuman PrimatesAgne Taraseviciute, Victor Tkachev, Rafael Ponce, et al.Cancer Discovery|February 9, 2018
CD10+GPR77+ Cancer-Associated Fibroblasts Promote ChemoresistanceCancer Discovery|March 16, 2018
Direct-to-Consumer Test for BRCA Mutations AuthorizedCancer Discovery|March 31, 2018
Cost the Focus of Cancer Panel ReportCancer Discovery|April 4, 2013
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumorJ Keith Killian, Su Young Kim, Markku Miettinen, et al.Cancer Discovery|February 7, 2013
Outlier kinase expression by RNA sequencing as targets for precision therapyVishal Kothari, Iris Wei, Sunita Shankar, et al.Cancer Discovery|February 13, 2013
Maximizing the benefits of off-target kinase inhibitor activityMonica Red Brewer, William PaoPageof 427